Lamivudine and Zidovudine
NDC 76282-115, Lamivudine and Zidovudine, tablet, film coated, from Exelan Pharmaceuticals Inc..
- Product NDC
- 76282-115
- Status
- Listed
- Labeler
- Exelan Pharmaceuticals Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203259
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76282-115 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LAMIVUDINE150 mg/1
- ZIDOVUDINE300 mg/1
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Analog [EXT]; Nucleoside Analog [EXT]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76282-115-05 | 76282011505 | 500 TABLET, FILM COATED in 1 BOTTLE (76282-115-05) |
| 76282-115-60 | 76282011560 | 60 TABLET, FILM COATED in 1 BOTTLE (76282-115-60) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/4cf565c3-bdec-4c18-93c1-cc7fa8331c90
Use it
Look up 76282-115 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76282-115 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76282-115. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.